The role of macrophages in cancer development and therapy E Cendrowicz, Z Sas, E Bremer, TP Rygiel Cancers 13 (08), 1946, 2021 | 206 | 2021 |
Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options Z Sas, E Cendrowicz, I Weinhäuser, TP Rygiel International Journal of Molecular Sciences 23 (7), 3778, 2022 | 69 | 2022 |
Bacillus subtilis SepF Binds to the C-Terminus of FtsZ E Cendrowicz, SP van Kessel, LS van Bezouwen, N Kumar, EJ Boekema, ... PloS one 7 (8), e43293, 2012 | 65 | 2012 |
Antibacterial activity of alkyl gallates is a combination of direct targeting of FtsZ and permeabilization of bacterial membranes E Król, A de Sousa Borges, I da Silva, CR Polaquini, LO Regasini, ... Frontiers in microbiology 6, 138204, 2015 | 64 | 2015 |
FtsZ polymerization assays: simple protocols and considerations E Król, DJ Scheffers JoVE (Journal of Visualized Experiments), e50844, 2013 | 44 | 2013 |
CD47 expression defines efficacy of rituximab with CHOP in non–germinal center B-cell (non-GCB) diffuse large B-cell lymphoma patients (DLBCL), but not in GCB DLBCL R Bouwstra, Y He, J de Boer, H Kooistra, E Cendrowicz, RSN Fehrmann, ... Cancer immunology research 7 (10), 1663-1671, 2019 | 39 | 2019 |
CD24 is a potential immunotherapeutic target for mantle cell lymphoma JÁ Freile, N Ustyanovska Avtenyuk, MG Corrales, HJ Lourens, G Huls, ... Biomedicines 10 (5), 1175, 2022 | 24 | 2022 |
FtsZ-dependent elongation of a coccoid bacterium AR Pereira, J Hsin, E Król, AC Tavares, P Flores, E Hoiczyk, N Ng, ... MBio 7 (5), 10.1128/mbio. 00908-16, 2016 | 24 | 2016 |
Galectin-9 triggers neutrophil-mediated anticancer immunity N Ustyanovska Avtenyuk, G Choukrani, E Ammatuna, T Niki, ... Biomedicines 10 (1), 66, 2021 | 14 | 2021 |
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity E Cendrowicz, L Jacob, S Greenwald, A Tamir, I Pecker, R Tabakman, ... Journal of Experimental & Clinical Cancer Research 41 (1), 97, 2022 | 13 | 2022 |
Metal-dependent SpoIIE oligomerization stabilizes FtsZ during asymmetric division in Bacillus subtilis E Cendrowicz, A de Sousa Borges, M Kopacz, DJ Scheffers PLoS One 12 (3), e0174713, 2017 | 12 | 2017 |
DSP107, a novel bi-functional fusion protein that combines inhibition of CD47 with targeted activation of 4-1BB to trigger innate and adaptive anticancer immune responses E Cendrowicz, L Jacob, S Greenwald, A Tamir, Y Gozlan, G Huls, ... Blood 136, 19-20, 2020 | 7 | 2020 |
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL. Cancer … R Bouwstra, Y He, J De Boer, H Kooistra, E Cendrowicz, RSN Fehrmann, ... CIR-18-0781.[Abstract][CrossRef][Google Scholar], 0 | 6 | |
Pharmacodynamic Effects of Nirogacestat, a Gamma Secretase Inhibitor, on B-Cell Maturation Antigen in Healthy Participants T Shearer, RL Williams, M Johnson, E Cendrowicz, C Leonowens, ... Blood 140 (Supplement 1), 3080-3081, 2022 | 2 | 2022 |
Population pharmacokinetic-pharmacodynamic model of nirogacestat effects on B-cell maturation antigen in healthy subjects. T Shearer, RL Williams, M Johnson, E Cendrowicz, C Leonowens, ... Journal of Clinical Oncology 41 (16_suppl), 8027-8027, 2023 | 1 | 2023 |
Innate immune checkpoint inhibitors for treatment of Diffuse Large B-cell Lymphoma R Bouwstra | | 2022 |
P01. 09 Dual signalling protein 107 triggers innate and adaptive immune response towards tumour cells E Cendrowicz, LJ Jacob, S Greenwald, G Huls, M Dranitzki-Elhalel, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
DSP107—a first in class, bifunctional, fusion protein targeting both innate and adaptive immunity A Foley-Comer, S Greenwald, E Cendrowicz, R Tabakman, S Amsili, ... Journal for immunotherapy of cancer 7, 2019 | | 2019 |
Interactions of cell division protein FtsZ with large and small molecules E Cendrowicz | | 2016 |